Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Debbie P Hagins"'
Autor:
Moti Ramgopal, Anson Wurapa, Axel Baumgarten, Mezgebe Berhe, Anton Pozniak, Chloe Orkin, Juan Manuel Tiraboschi, Debbie P Hagins, Hailin Huang, Kristin Andreatta, Nathan Unger, Jason Hindman, Hal Martin, Jared Baeten, Olayemi Osiyemi
Publikováno v:
Open Forum Infectious Diseases. 9
Background People with HIV (PWH) who are initiated on guidelines-recommended first-line INSTI-based antiretroviral therapy routinely achieve rapid virologic suppression; however, those with a high baseline (BL) HIV-1 RNA and/or low CD4 count may be m
Autor:
Jean-Michel Molina, Kathleen Squires, Paul E Sax, Pedro Cahn, Johan Lombaard, Edwin DeJesus, Ming-Tain Lai, Anthony Rodgers, Lisa Lupinacci, Sushma Kumar, Peter Sklar, George J Hanna, Carey Hwang, Elizabeth Anne Martin, Debbie P. Hagins, Olayemi O. Osiyemi, David James Prelutsky, Moti N. Ramgopal, Anthony John Scarsella, Robin Dretler, Christopher J. Bettacchi, James Sims, Patrick G. Clay, Nicholaos C. Bellos, Melanie A. Thompson, Jose Montero, Cheryl K. McDonald, Catherine Creticos, David Shamblaw, Miguel Mogyoros, Antonio E. Terrelonge, Martin Valdes, Karen T. Tashima, William J. Robbins, Franco Antonio Felizarta, Richard A. Elion, Jihad Slim, Sandra S. Win, Sujata N. Lalla-Reddy, Peter Jerome Ruane, Anthony Mills, Jerry L. Cade, Craig A. Dietz, David Scott Rubin, Cynthia Mayer, Juan Carlos Rondon, Paul P. Cook, Eric Daar, Princy N. Kumar, Susan Swindells, Jose Guillermo Castro, Ivan Melendez-Rivera, Javier O. Morales-Ramirez, Lizette Santiago, Jorge L. Santana-Bagur, Marcelo Martins, Pedro Enrique Cahn, Gustavo D. Lopardo, Norma Porteiro, Mark Theo Bloch, David Alfred Baker, Norman Roth, Richard James Moore, Robert James Finlayson, James McMahon, Armin Rieger, Alexander Zoufaly, Sylvia Hartl, Robert Zangerle, Fiona Smaill, Sharon L. Walmsley, Brian Conway, Anita Rachlis, Graham H.R. Smith, Carlos Perez, Alejandro Afani, Maria Isabel Campos, Carolina Eugenia Chahin, Marcelo Wolff Reyes, Jan Gerstoft, Nina Weis, Alex Lund Laursen, Yazdan Yazdanpanah, Laurent Cotte, Francois Raffi, Philippe Morlat, Pierre-Marie Girard, Christine Katlama, Juergen K. Rockstroh, Keikawus Arasteh, Stefan Esser, Albrecht Stoehr, Hans-Juergen Stellbrink, Matthias Stoll, Dirk Schuermann, Gerd Faetkenheuer, Johannes Bogner, Thomas Lutz, Axel Baumgarten, Hans Jaeger, Andrea Gori, Gabriel Coltan, Felicia Constandis, Simona Manuela Erscoiu, Liviu-Jany Prisacariu, Sorin Rugina, Adrian Streinu-Cercel, Vadim Valentinovich Pokrovsky, Natalia V. Zakharova, Andrey Anatolyevich Shuldyakov, Elena Pavlovna Ryamova, Valeriy Viktorovich Kulagin, Olga Aleksandrovna Tsybakova, Elena Orlova-Morozova, Firaya Nagimova, Evgeniy Voronin, Tatyana Evgenyevna Shimonova, Oleg Anatolyevich Kozyrev, Catherine Orrell, Johannes Jurgens Lombaard, Marleen de Jager, Joaquin Portilla Segorb, Josep Mallolas, Maria Jesus Perez Elias, Josep M. Gatell, Jose Ramon Arribas Lopez, Eugenia Negredo Puigmal, Daniel Podzamczer Palter, Federico Pulido Ortega, Jesus Troya Garcia, Ignacio De los Santos Gil, Juan Berenguer Berenguer, Ian G. Williams, Margaret A. Johnson, Gabriel Schembri, Amanda Clarke, Mark Gompels, Julie Meriel Fox, Steven John Taylor, David Harold Dockrell, Stephen Kegg
Publikováno v:
The Lancet HIV. 7:e16-e26
Doravirine is a novel, non-nucleoside reverse transcriptase inhibitor that has shown non-inferior efficacy to ritonavir-boosted darunavir, with a superior lipid profile, in adults with HIV who were treatment naive at week 48 in the phase 3 DRIVE-FORW
Autor:
Catherine Orrell, Debbie P Hagins, Elena Belonosova, Norma Porteiro, Sharon Walmsley, Vicenç Falcó, Choy Y Man, Alicia Aylott, Ann M Buchanan, Brian Wynne, Cindy Vavro, Michael Aboud, Kimberly Y Smith, Pedro Enrique Cahn, Lidia Isabel Cassetti, Norma Porteiro Barreira, Jonathan Benjamin Angel, Alexandra de Pokomandy, Marianne Harris, Anita R. Rachlis, Sharon L. Walmsley, Clotilde Allavena, Oliver Bouchaud, Caroline Gatey, Agathe Rami, Salvatore Casari, Giovanni Di Perri, Adriano Lazzarin, Franco Maggiolo, Giovanni Penco, Tiziana Quirino, Giuliano Rizzardini, Jaime-Federico Andrade-Villanueva, Juan G. Sierra-Madero, Teresa Branco, Rosario Serrao, Eugenio JR. Teofilo, Ivan Melendez-Rivera, Lizette Santiago, Carmen D. Zorrilla, Oksana E. Chernova, Vadim Pokrovsky, Aza Gasanovna Rakhmanova, Olga Tsybakova, Eugene Voronin, Tasneem Vally, Livhuwani ML. Farisani, Boitumelo Lucrecia Sebopa, Carlos Aguado Barros, Alfredo Cano Sánchez, Manuel Castaño, Vicens Falcó Ferrer, Juan J. González García, Jose Hernandez-Quero, Eugenia Negredo Puigmal, María Jesús Pérez Elías, Daniel Podzamczer Palter, Joaquin Sogorb Portilla, Pompeyo Viciana Fernández, Weerawat Manosuthi, Kiat Ruxrungtham, David H. Dockrell, Phillip E. Hay, Margaret A. Johnson, Nicola E. Mackie, Chloe M. Orkin, Steve Taylor, Laveeza Bhatti, Indira Brar, Robert Owen Brennan, Jerry L. Cade, Beata Casanas, Kathleen Casey, Douglas Cunningham, Edwin DeJesus, Craig Dietz, Robin Henry Dretler, Joseph J. Eron, Franco Antoni B. Felizarta, Kenneth H. Fife, Debbie P. Hagins, Margaret Hoffman-Terry, Mamta Jain, Marc Alexander Johnson, Clifford A. Kinder, Princy N. Kumar, Stanley T. Lewis, Cheryl Kay McDonald, Armando D. Meza, Karam C. Mounzer, Cheryl L. Newman, Olayemi O. Osiyemi, Ronald Poblete, Rachel M. Presti, Moti Ramgopal, Joel Rosenstock, Rafik Samuel, Uriel Sebastian Sandkovsky, Alyssa So Young Shon, Daniel J. Skiest, Louis M. Sloan, Catherine B. Small, Pablo Tebas, Cornelius N. Van Dam
Publikováno v:
The lancet. HIV. 4(12)
Summary Background Dolutegravir is a once-daily integrase strand transfer inhibitor with no need for pharmacokinetic boosting that is approved for the treatment of HIV-1 infection. Because women are often under-represented in HIV clinical trials, we
Autor:
Jean-Michel Molina, Kathleen Squires, Paul E Sax, Pedro Cahn, Johan Lombaard, Edwin DeJesus, Ming-Tain Lai, Xia Xu, Anthony Rodgers, Lisa Lupinacci, Sushma Kumar, Peter Sklar, Bach-Yen Nguyen, George J Hanna, Carey Hwang, Marcelo Martins, Pedro Enrique Cahn, Gustavo D. Lopardo, Norma Porteiro, Mark Theo Bloch, David Alfred Baker, Norman Roth, Richard James Moore, Robert James Finlayson, James McMahon, Armin Rieger, Alexander Zoufaly, Sylvia Hartl, Robert Zangerle, Fiona Smaill, Sharon L. Walmsley, Brian Conway, Anita Rachlis, Graham H.R. Smith, Carlos Perez, Alejandro Afani, Maria Isabel E. Campos Barker, Carolina Eugenia Chahin, Marcelo Wolff Reyes, Jan Gerstoft, Nina Weis, Alex Lund Laursen, Yazdan Yazdanpanah, Laurent Cotte, Francois Raffi, Philippe Morlat, Pierre-Marie Girard, Christine Katlama, Juergen K. Rockstroh, Keikawus Arasteh, Stefan Esser, Albrecht Stoehr, Hans-Juergen Stellbrink, Matthias Stoll, Dirk Schuermann, Gerd Faetkenheuer, Johannes Bogner, Thomas Lutz, Axel Baumgarten, Hans Jaeger, Andrea Gori, Gabriel Coltan, Felicia Constandis, Simona Manuela Erscoiu, Liviu-Jany Prisacariu, Sorin Rugina, Adrian Streinu-Cercel, Vadim Valentinovich Pokrovsky, Natalia V. Zakharova, Andrey Anatolyevich Shuldyakov, Elena Pavlovna Ryamova, Valeriy Viktorovich Kulagin, Olga Aleksandrovna Tsybakova, Elena Orlova-Morozova, Firaya Nagimova, Evgeniy Voronin, Tatyana Evgenyevna Shimonova, Oleg Anatolyevich Kozyrev, Catherine Orrell, Johannes Jurgens Lombaard, Margaretha Elizabeth Botes, Joaquin Portilla, Josep Maria Gatell, Maria Jesus Perez, Jose Ramon Arribas, Eugenia Negredo, Daniel Podzamczer, Federico Pulido, Jesus Troya, Ignacio De los Santos, Juan Berenguer, Ian G. Williams, Margaret A. Johnson, Gabriel Schembri, Amanda Clarke, Mark Gompels, Julie Meriel Fox, Steven John Taylor, Stephen Kegg, Debbie P. Hagins, Olayemi O. Osiyemi, David James Prelutsky, Moti N. Ramgopal, Robin Dretler, Louis Sloan, Stanley T. Lewis, Patrick G. Clay, Nicholaos C. Bellos, Melanie A. Thompson, Jose Montero, Cheryl K. McDonald, Catherine Creticos, David Shamblaw, Antonio E. Terrelonge, Martin Valdes, Karen T. Tashima, William J. Robbins, Franco Antonio Felizarta, Richard A. Elion, Jihad Slim, Jacob Paul Lalezari, Sujata N. Lalla-Reddy, Peter Jerome Ruane, Anthony Mills, Jerry L. Cade, Rafael E. Campo, Craig A. Dietz, Gary Blick, Cynthia Mayer, Juan Carlos Rondon, Paul P. Cook, Eric Daar, Princy N. Kumar, Susan Swindells, Jose Guillermo Castro, Javier O. Morales-Ramirez, Lizette Santiago, Jorge L. Santana-Bagur
Publikováno v:
The lancet. HIV. 5(5)
Summary Background Doravirine is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) with a pharmacokinetic profile supporting once-daily dosing, and potent in-vitro activity against the most common NNRTI-resistant HIV-1 variants. We compa
Autor:
Bisher, Akil, Gary, Blick, Debbie P, Hagins, Moti N, Ramgopal, Gary J, Richmond, Rafik M, Samuel, Naomi, Givens, Cindy, Vavro, Ivy H, Song, Brian, Wynne, Mounir, Ait-Khaled, David, Wright
Publikováno v:
Antiviral Therapy. 20:343-348
Background The Phase III VIKING-3 study demonstrated that dolutegravir (DTG) 50 mg twice daily was efficacious in antiretroviral therapy (ART)-experienced subjects habouring raltegravir- and/or elvitegravir-resistant HIV-1. VIKING-4 (ING116529) inclu